![]() | |
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C26H39NO3 |
Molar mass | 413.602 g·mol−1 |
3D model (JSmol) | |
| |
|
AM-11245 is a drug which is a cannabinoid agonist from the classical cannabinoid family. It has high affinity and efficacy at both the CB1 and CB2 cannabinoid receptors, with a Ki of 0.4nM at both CB1 and CB2, and an EC50 of ~0.06nM at CB1 and 0.2nM at CB2, making it one of the most potent cannabinoid agonists identified to date.[1]
See also
[edit]References
[edit]- ^ Jiang S, Iliopoulos-Tsoutsouvas C, Tong F, Brust CA, Keenan CM, Raghav JG, et al. (April 2021). "Novel Functionalized Cannabinoid Receptor Probes: Development of Exceptionally Potent Agonists". Journal of Medicinal Chemistry. 64 (7): 3870–3884. doi:10.1021/acs.jmedchem.0c02053. PMID 33761251. S2CID 232355437.